Download PDF
Homœopathic Links 2023; 36(04): 281-286
DOI: 10.1055/s-0043-1772239
Original Article

A Randomized Trial of Three Homeopathic Drugs: Rauwolfia serpentina, Viscum album, and Spartium scoparium in Essential Hypertension

Dibyendu Mandal 
1   Department of Homoeopathic Pharmacy, D. N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Soumyadeep Maity 
2   D. N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Abdur Rahaman Shaikh 
3   Department of Practice of Medicine, D. N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Sabir Ahamed 
4   Department of Surgery, D. N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Priyanka Ghosh 
5   Department of Organon of Medicine and Homoeopathic Philosophy, D. N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Shyamal Kumar Mukherjee 
6   Deptartment of Community Medicine, D. N. De Homoeopathic Medical College and Hospital, Kolkata, India
,
Munmun Koley 
7   Department of Homoeopathy, East Bishnupur State Homoeopathic Dispensary, Chandi Daulatabad Block Primary Health Centre, South 24 Parganas, West Bengal, under Department of Health & Family Welfare, Govt. of West Bengal, India
,
Subhranil Saha 
8   Department of Repertory, D. N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Hypertension (HTN) remains one of the major risk factors for heart failure, stroke, and coronary heart disease worldwide. This study was undertaken to compare the antihypertensive effects produced by the mother tinctures (MTs) of three homeopathic drugs—Rauwolfia serpentina (RS), Viscum album (VA), and Spartium scoparium (SS; also known as Cytisus scoparius [CS]) in essential hypertension. This open-label, randomized, three parallel arm, pragmatic, pilot trial was conducted on 60 participants with essential hypertension in the outpatient department of D. N. De Homoeopathic Medical College and Hospital, Kolkata. Participants were randomized into three groups: RS, VA, and SS equally. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured at baseline and after 30 and 60 minutes. Group differences at different time points and overall were measured using one-way analysis of variance (ANOVA) and three-way repeated measure ANOVA models, respectively, after adjusting for baseline differences using intention-to-treat approaches. A p value less than 0.05 was considered statistically significant. Endpoint analysis included 60 participants. Although the highest mean reductions in SBP and DBP with time were achieved in the RS group, all three medicines revealed similar antihypertensive effects without any significant differences (SBP: F 2, 57 = 1.710, p = 0.190; DBP: F 2, 57 = 0.732, p = 0.485). No harm or serious adverse events were reported from either of the groups. All three medicines (RS, VA, and SS) produced similar antihypertensive effects in essential hypertension.

Trial registration: CTRI/2021/02/031548; UTN: U1111–1264–6856.

Keywords

homeopathy - hypertension - Rauwolfia serpentina - Viscum album - Spartium scoparium

Author Contributions

D.M., S.M., and S.K.M. were responsible for concept development and literature search. D.M., S.M., A.R.S., S.A., and P.G. contributed to clinical study and data acquisition. P.G., M.K., and S.S. were responsible for the concept, study design, data interpretation, statistical analysis, and preparation of the article. All the authors reviewed and approved the final version of the article.


Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Supplementary Material



Publication History

Article published online:
16 October 2023

© 2023. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Mohan H. Textbook of Pathology. 7th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2015: 675
    CrossrefGoogle Scholar
  • 2 Shah SN, Munjal YP, Kamath SA. et al. Indian guidelines on hypertension-IV (2019). J Hum Hypertens 2020; 34 (11) 745-758
    CrossrefPubMedGoogle Scholar
  • 3 Williams B, Mancia G, Spiering W. et al; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39 (33) 3021-3104
    CrossrefPubMedGoogle Scholar
  • 4 Kasper D, Fauci A, Hauser S. et al. Harrison's Principles of Internal Medicine. Vol II. 20th ed. New York, NY: McGraw-Hill Education; 2015: 1895 , 1891–1894, 1901
    Google Scholar
  • 5 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary—A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71 (06) 1269-1324
    CrossrefPubMedGoogle Scholar
  • 6 World Health Organization. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. World Health Day. Geneva: WHO; 2013 . Available from: http://www.ishworld.com/downloads/pdf/global_brief_hypertension.pdf . Accessed May 2, 2022
    PubMedGoogle Scholar
  • 7 Sarkar T, Singh NP. Epidemiology and genetics of hypertension. J Assoc Physicians India 2015; 63 (09) 61-98
    PubMedGoogle Scholar
  • 8 Ramakrishanan S, Gupta K. Prevalence of hypertension among Indian adults: results from the great India blood pressure survey. Indian Heart J 2020; 72 (03) 217
    CrossrefPubMedGoogle Scholar
  • 9 World Health Organization. Hypertension. Accessed May 04, 2022 at: https://www.who.int/news-room/factsheets/detail/hypertension
    PubMedGoogle Scholar
  • 10 Alley WD, Schick MA. Hypertensive Emergency. Treasure Island, FL: StatPearls Publishing; 2023
    Google Scholar
  • 11 Elliott WJ, Varon J. Drugs used for the treatment of hypertensive emergencies. Accessed June 16, 2023 at: https://www.uptodate.com/contents/drugs-used-for-the-treatment-of-hypertensive-emergencies
    PubMedGoogle Scholar
  • 12 Balahura A-M, Moroi S-I, Scafa-Udrişte A. et al. The management of hypertensive emergencies-is there a “magical” prescription for all?. J Clin Med 2022; 11 (11) 3138
    CrossrefPubMedGoogle Scholar
  • 13 Tsioufis C, Thomopoulos C. Combination drug treatment in hypertension. Pharmacol Res 2017; 125 (Pt B): 266-271
    CrossrefPubMedGoogle Scholar
  • 14 Ferdinand KC, Nasser SA. Management of essential hypertension. Cardiol Clin 2017; 35 (02) 231-246
    CrossrefPubMedGoogle Scholar
  • 15 Tripathi KD. Essentials of Medical Pharmacology. 8th ed. New Delhi: Jaypee Brothers Medical Publishers; 2019: 620 , 533, 537
    Google Scholar
  • 16 Herman LL, Bashir K. Hydrochlorothiazide. Treasure Island, FL: StatPearls Publishing; 2022
    Google Scholar
  • 17 Chen R, Suchard MA, Krumholz HM. et al. Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension 2021; 78 (03) 591-603
    CrossrefPubMedGoogle Scholar
  • 18 Olowofela AO, Isah AO. A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria. Ann Afr Med 2017; 16 (03) 114-119
    CrossrefPubMedGoogle Scholar
  • 19 Melville S, Byrd JB. Personalized medicine and the treatment of hypertension. Curr Hypertens Rep 2019; 21 (02) 13
    CrossrefPubMedGoogle Scholar
  • 20 Ali-Shtayeh MS, Jamous RM, Jamous RM, Salameh NM. Complementary and alternative medicine (CAM) use among hypertensive patients in Palestine. Complement Ther Clin Pract 2013; 19 (04) 256-263
    CrossrefPubMedGoogle Scholar
  • 21 Mehra P. Usefulness of homoeopathy in essential hypertension: an exploratory interventional trial. International J High Dilution Res 2015; 14: 16-19
    CrossrefPubMedGoogle Scholar
  • 22 Saha S, Koley M, Hossain SI. et al. Individualized homoeopathy versus placebo in essential hypertension: a double-blind randomized controlled trial. Indian J Res Homoeopathy 2013; 7: 62-71
    CrossrefPubMedGoogle Scholar
  • 23 Sadhukhan S, Singh S, Michael J. et al. Individualized homeopathic medicines in Stage I essential hypertension: a double-blind, randomized, placebo-controlled pilot trial. J Altern Complement Med 2021; 27 (06) 515-521
    CrossrefPubMedGoogle Scholar
  • 24 Varanasi R, Kolli R, Rai Y. et al. Effects of individualised homoeopathic intervention in stage I essential hypertension: a single-blind, randomised, placebo-controlled trial. Indian J Res Homoeopathy 2020; 14: 3-14
    CrossrefPubMedGoogle Scholar
  • 25 Azmi MB, Sultana S, Naeem S, Qureshi SA. In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase. Saudi J Biol Sci 2021; 28 (01) 731-737
    CrossrefPubMedGoogle Scholar
  • 26 Tsekouras V, Mavrikou S, Vlachakis D. et al. Proteome analysis of leaf, stem and callus in Viscum album and identification of lectins and viscotoxins with bioactive properties. Plant Cell Tissue Organ Cult 2020; 141: 167-178
    CrossrefPubMedGoogle Scholar
  • 27 Lobay D. Rauwolfia in the treatment of hypertension. Integr Med (Encinitas) 2015; 14 (03) 40-46
    PubMedGoogle Scholar
  • 28 Shamon SD, Perez MI. Blood pressure-lowering efficacy of reserpine for primary hypertension. Cochrane Database Syst Rev 2016; 12 (12) CD007655
    PubMedGoogle Scholar
  • 29 Weir MR. Corrigendum to: Reserpine: a new consideration of an old drug for refractory hypertension. Am J Hypertens 2020; 33 (12) 1150
    CrossrefPubMedGoogle Scholar
  • 30 Rastogi DP, Baig H. Rauwolfia serpentina (Aqua): a new approach in the treatment of hypertension in homoeopathy. CCRH Q Bull 1996; 18: 22-24
    PubMedGoogle Scholar
  • 31 Poruthukaren KJ, Palatty PL, Baliga MS, Suresh S. Clinical evaluation of Viscum album mother tincture as an antihypertensive: a pilot study. J Evid Based Complementary Altern Med 2014; 19 (01) 31-35
    CrossrefPubMedGoogle Scholar
  • 32 Jack RAF. Severe hypertension treated with Spartium and the constitutional homoeopathic remedy. Brit Hom J 1979; 68: 39-50
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 World Medical Association.. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 2001; 79 (04) 373-374
    PubMedGoogle Scholar
  • 34 Banerjee A, Nahar L, Bhat SA. et al. Effectiveness of adjunctive mother tinctures to individualized homeopathic treatment of chronic obstructive pulmonary diseases: an open randomized pragmatic pilot trial. Homoeopathic Links 2020; 33: 7-17
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Nayak C, Pattanaik N, Chattopadhyay A. et al. Individualized homeopathic medicines and Urtica urens mother tincture in treatment of hyperuricemia: an open, randomized, pragmatic, pilot trial. J Complement Integr Med 2020; 18 (03) 599-608
    CrossrefPubMedGoogle Scholar
  • 36 Singh S, Karwasra R, Kalra P. et al. Role of homoeopathic mother tinctures in rheumatoid arthritis: an experimental study. Indian J Res Homoeopathy 2015; 9: 42-48
    CrossrefPubMedGoogle Scholar
  • 37 Patwardhan B, Mutalik G, Tillu G. Drug discovery and ayurveda. In: Integrative Approaches for Health: Biomedical Research, Ayurveda and Yoga. St Louis, MO: Academic Press; 2015: 229-258
    Google Scholar
  • 38 Banerjee S, Debnath PK, Saikia AK. Herbal anti-tubercular adjunct therapy from “Bedside to Bench”: chromatography and in-silico studies of Vedic plant Aswagandha (Withania somnifera) as anti-tubercular adjunct therapy. Germany: Lap Lambert Academic Publishing GmbH KG; 2014
    Google Scholar
  • 39 Ministry of Health. Homoeopathic Pharmacopoeia of India. Vol. 6. New Delhi: Ministry of Health, Government of India; 1990
    Google Scholar
  • 40 Verma PN, Vaid I. eds. Encyclopedia of Homoeopathic Pharmacopoeia and Drug Index. 4 Vols. Updated ed. New Delhi: B. Jain Publishers (P) Ltd; 2007: 3017
    Google Scholar
  • 41 Schulz KF, Altman DG, Moher D. CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332
    CrossrefPubMedGoogle Scholar
  • 42 Dean ME, Coulter MK, Fisher P, Jobst K, Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Homeopathy 2007; 96 (01) 42-45
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Boericke W. Boericke's New Manual of Homoeopathic Materia Medica with Repertory. 28th ed. New Delhi: B. Jain Publishers (P). Ltd; 2011: 528-529
    Google Scholar
  • 44 Anshutz EP. New, Old and Forgotten Remedies. 6th ed. New Delhi: B. Jain Publishers (P) Ltd; 2019: 539
    Google Scholar
  • 45 Clarke JH. The Prescriber. 34th ed. New Delhi: B. Jain Publishers (P) Ltd; 2019: 201-202
    Google Scholar